NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.

The NOA-03 trial explored high-dose methotrexate alone in 37 patients with primary central nervous system lymphoma. The overall median survival was 25 months. After 4 years, the rate of leukoencephalopathy in patients surviving more than 12 months was 58% with and 10% without whole-brain radiotherap...

書誌詳細
主要な著者:	Herrlinger, U, Küker, W, Uhl, M, Blaicher, H, Karnath, H, Kanz, L, Bamberg, M, Weller, M
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
著者:: Herrlinger, U, 等
出版事項: (2002)

Primary central nervous system (CNS) lymphoma in immunocompetent patients.
著者:: Plasswilm, L, 等
出版事項: (2002)

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.
著者:: Küker, W, 等
出版事項: (2005)

Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
著者:: Küker, W, 等
出版事項: (2005)

MRI features of primary central nervous system lymphomas at presentation.
著者:: Bühring, U, 等
出版事項: (2001)

Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
著者:: Küker, W, 等
出版事項: (2002)

PCV salvage chemotherapy for recurrent primary CNS lymphoma.
著者:: Herrlinger, U, 等
出版事項: (2000)

Primary CNS lymphoma in the spinal cord: clinical manifestations may precede MRI detectability.
著者:: Herrlinger, U, 等
出版事項: (2002)

Radiomic prediction for durable response to high‐dose methotrexate‐based chemotherapy in primary central nervous system lymphoma
著者:: Haoyi Li, 等
出版事項: (2024-09-01)

First-line therapy with temozolomide induces regression of primary CNS lymphoma.
著者:: Herrlinger, U, 等
出版事項: (2002)

Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma
著者:: Xianggui Yuan, 等
出版事項: (2024-02-01)

Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
著者:: Küker, W, 等
出版事項: (2005)

High-Dose Methotrexate for the Treatment of Relapsed Central Nervous System Erdheim-Chester Disease
著者:: Prahlad Ho, 等
出版事項: (2014-01-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
著者:: Clare J. Twist, 等
出版事項: (2013-01-01)

Leptomeningeal metastasis: survival and prognostic factors in 155 patients.
著者:: Herrlinger, U, 等
出版事項: (2004)

Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
著者:: Maciej Tatarczuch, 等
出版事項: (2024-08-01)

Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma
著者:: Julia Wendler, 等
出版事項: (2025-01-01)

Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease.
著者:: Herrlinger, U, 等
出版事項: (2003)

Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience
著者:: Adam Suleman, 等
出版事項: (2022-12-01)

Acridios del NOA IV
著者:: Sonia Z. Turk
出版事項: (2020-10-01)

Acridoideos del NOA. V
著者:: Sonia Z. Turk
出版事項: (2020-10-01)

Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients
著者:: Rudy Birsen, 等
出版事項: (2018-07-01)

Primary CNS lymphoma: Diagnosis and treatment
著者:: Herrlinger, U, 等
出版事項: (2003)

The pharmacogenetics of methotrexate in inflammatory bowel disease.
著者:: Herrlinger, K, 等
出版事項: (2005)

P1223: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZRMA REGIMEN（ZANUBRUTINIB, RITUXIMAB, METHOTREXATE AND CYTARABINE)
著者:: Y. Tang
出版事項: (2022-06-01)

PB2315: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZR OR ZRM REGIMEN (ZANUBRUTINIB, RITUXIMAB, METHOTREXATE)
著者:: Yue Teng, 等
出版事項: (2023-08-01)

P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH INTENSIFIED R-ACVBP STRATEGY
著者:: L. Renaud, 等
出版事項: (2022-06-01)

The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first‐line methotrexate treatment: A retrospective study
著者:: Yan Zhang, 等
出版事項: (2024-05-01)

Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
著者:: Zhiyong Zeng, 等
出版事項: (2024-09-01)

Oral methotrexate in ulcerative colitis.
著者:: Cummings, JR, 等
出版事項: (2005)

Treatment of primary central nervous system lymphomas
著者:: I. V. Cherkashina, 等
出版事項: (2021-06-01)

Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high‐dose intravenous methotrexate, rituximab, and temozolomide: A case report
著者:: Ikhwan Rinaldi, 等
出版事項: (2024-03-01)

P1145: PRELIMINARY RESULTS OF PENPULIMAB COMBINED WITH RMA(RITUXIMAB, METHOTREXATE, AND CYTARABINE) FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
著者:: Haorui Shen, 等
出版事項: (2023-08-01)

The cortical substrate of visual extinction.
著者:: Karnath, H, 等
出版事項: (2003)

Central nervous system involvement in non-Hodgkin's lymphoma
著者:: M T Kutluk, 等
出版事項: (1988-01-01)

COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
著者:: Giuseppina Massini, 等
出版事項: (2009-11-01)

COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
著者:: Stefan Hohaus, 等
出版事項: (2009-12-01)

III° Jornadas de Historia Reciente del NOA
著者:: Alicia Gartner
出版事項: (2017-11-01)

Adverse Oral Reactions Associated with Low Doses of Methotrexate
著者:: N. V. Izmozherova, 等
出版事項: (2020-12-01)

Prevention and management of secondary central nervous system lymphoma
著者:: Sabela Bobillo, 等
出版事項: (2022-11-01)